Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 715 Records) |
Query Trace: VKORC1[original query] |
---|
Association of VKORC1 polymorphisms and major bleedings in patients who are treated with vitamin K antagonists. Journal of internal medicine 2022 Sep . van Heteren D Max, Lijfering Willem M, van der Meer Felix J M, Reitsma Pieter H, Swen Jesse J, Bos Mettine H A, van Rein Nien |
Correlation between CYP2C9 gene polymorphism and warfarin dose in Chinese Han population with coronary heart disease. Cellular and molecular biology (Noisy-le-Grand, France) 2021 Dec 67 (5): 157-163. Zuo Qiyu, Li Li, Zhong Mingjing, Chen Gengbiao, Xio Junh |
Determination of Pleiotropic Effect of Warfarin in VKORC1 and CYP2C9 Genotypes in Patients With Heart Valve Replacement. Frontiers in cardiovascular medicine 2022 6 9 895169. Shafique Huma, Ashraf Naeem Mahmood, Rashid Amir, Majeed Asifa, Afsar Tayyaba, Daly Ann K, Almajwal Ali, Alruwaili Nawaf W, Khan Azmat Ullah, Razak Suha |
Frequency Distribution of CYP2C9 and VKORC1 Mutations among Bulgarian Patients and their Importance for Anticoagulant Therapy. Clinical laboratory 2022 12 68 (12): . Velizarova Milena, Abedinov Philip, Svinarov Dobrin, Nikolov Valentin, Hristova Julie |
Pharmacogenetics of warfarin and healthcare costs - Real-world data analysis. Pharmacoepidemiology and drug safety 2022 12 32 (3): 382-386. Lähteenmäki Jaakko, Vuorinen Anna-Leena, Lehto Mika, Niemi Mikko, Forsberg Markus |
Clinical significance of the series of CYP2C9*non3 variants, an unignorable predictor of warfarin sensitivity in Chinese population. Frontiers in cardiovascular medicine 2022 12 9 1052521. Wang Dongxu, Wu Hualan, Dong Min, Zhang Qing, Zhao Anxu, Zhao Xinlong, Chong Jia, Du Minghui, Wang Yan, Shi Haifeng, Wang Shuanghu, Wang Fang, Cai Jianping, Yang Jiefu, Dai Dapeng, Chen H |
Evaluation of supervised machine learning algorithms in predicting the poor anticoagulation control and stable weekly doses of warfarin. International journal of clinical pharmacy 2022 10 . Sridharan Kannan, Ramanathan Murali, Al Banna Rash |
Hyper-responsiveness to warfarin in a young patient with the VKORC1 -1639GA/CYP2C9*1*46 genotype: a case report. Thrombosis journal 2022 10 20 (1): 65. Aldiban Weam, Altawil Yara, Hussein Samir, Aljamali Majd, Youssef Lama |
Diversity of pharmacogenomic variants affecting warfarin metabolism in Sri Lankans. Pharmacogenomics 2022 10 23 (17): 917-923. Ranasinghe Priyanga, Sirisena Nirmala, Senadeera Vidarsha, Anandagoda Gayani, Dissanayake Vajira |
Influence of polymorphisms in CYP2C9, VKORC1, MDR1 and APOE genes on the warfarin maintenance dose in Brazilian patients. Pharmacogenomics 2023 9 . Emílio Itamar de Freitas Campos, Karina Braga Gomes, Daniel Dias Ribeiro, Marja Kaarina Puurunen, Aline de Oliveira Magalhães Mourão, Isadora Gonçalves Ferreira, Manoel Otávio da Costa Rocha, Renan Pedra de Souza, Maria Auxiliadora Parreiras Marti |
Association among VKORC1 rs9923231, CYP4F2 rs2108622, GGCX rs11676382 polymorphisms and acute ischemic stroke. Medicine 2023 9 102 (34): e34836. Silvina Ilu?, ?tefan Cristian Vesa, Vitalie V?c?ra?, Diana ?ipo?-Lascu, Cristina Bârsan, Raluca Maria Pop, Sorin Cri?an, Antonia Eugenia Macarie, Camelia Alexandra Coad?, L?cr?mioara Perju-Dumbrav?, Dafin Fior Muresanu, Anca Dana Buzoia |
Novel Gene Polymorphisms for Stable Warfarin Dose in a Korean Population: Genome-Wide Association Study. Biomedicines 2023 8 11 (8): . Jung Sun Kim, Sak Lee, Jeong Yee, Kyemyung Park, Eun Jeong Jang, Byung Chul Chang, Hye Sun Gw |
FREQUENCY OF VKORC1 AND CYP2C9 GENES POLYMORPHISM IN ABKHAZIAN POPULATION. Georgian medical news 2023 7 (338): 96-101. T Lezhava, N Kakauridze, T Jokhadze, T Buadze, M Gaiozishvili, Kh Gargulia, T Sig |
Computational Structural Validation of CYP2C9 Mutations and Evaluation of Machine Learning Algorithms in Predicting the Therapeutic Outcomes of Warfarin. Current drug metabolism 2023 7 . Kannan Sridharan, Thirumal Kumar, Suchetha Manikandan, Gaurav Prasanna, Lalitha G, Rashed Al Banna, George Priya Do |
Frequency of polymorphisms in the CYP2C9, VKORC1, and CYP4F2 genes related to the metabolism of Warfarin in healthy donors from Cali, Colombia. Medicine 2023 7 102 (30): e34204. Sebastian Giraldo-Ocampo, Lorena Diaz-Ordoñez, Yisther Katherine Silva-Cuero, Juan David Gutierrez-Medina, Estephania Candelo, Javier A Diaz, Harry Pachaj |
Optimisation of warfarin-dosing algorithms for Han Chinese patients with CYP2C9*13 variants. European journal of clinical pharmacology 2023 7 . Dongxu Wang, Hualan Wu, Qing Zhang, Xiaoyue Zhou, Yang An, Anxu Zhao, Jia Chong, Shuanghu Wang, Fang Wang, Jiefu Yang, Dapeng Dai, Hao Ch |
Genetic Factors Influencing Warfarin Dose in Han Chinese Population: A Systematic Review and Meta-Analysis of Cohort Studies. Clinical pharmacokinetics 2023 6 62 (6): 819-833. Zinan Zhao, Fei Zhao, Xiang Wang, Deping Liu, Junpeng Liu, Yatong Zhang, Xin Hu, Ming Zhao, Chao Tian, Shujie Dong, Pengfei J |
Pharmacogenomic profile of a central European urban random population-Czech population. PloS one 2023 4 18 (4): e0284386. Riccardo Proietti, Geraldo A Maranho Neto, Sarka Kunzova, Oriana Lo Re, Ari Ahola-Olli, Juho Heliste, Juan Pablo Gonzalez-Rivas, Manlio Vinciguer |
Development and validation wise assessment of genotype guided warfarin dosing algorithm in Indian population. Drug metabolism and personalized therapy 2023 4 . Aishwarya Anand, Rupesh Kumar, Swati Sharma, Ankur Gupta, Rajesh Vijayvergiya, Saurabh Mehrotra, Basant Kumar, Deepesh Lad, Amol N Patil, Nusrat Shafiq, Samir Malhot |
Evaluation of a warfarin dosing algorithm including CYP2C9, VKORC1, and CYP4F2 polymorphisms and non-genetic determinants for the Iranian population. Pharmacological reports : PR 2023 4 . Farajzadeh-Dehkordi Mahvash, Samiee-Rad Fatemeh, Farzam Seyed Saeed, Javadi Amir, Cheraghi Sara, Hamedi-Asl Dariush, Rahmani Bab |
The role of CYP2C9*2, CYP2C9*3 and VKORC1-1639 variants on the susceptibility of upper gastrointestinal bleeding: A full case-control study. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 2023 3 26 11136. Forgerini Marcela, Urbano Gustavo, De Nadai Tales Rubens, Batah Sabrina Setembre, Fabro Alexandre Todorovic, De Carvalho Mastroianni Patríc |
Time-to-event modeling for achieving a stable warfarin dose using genetic and non-genetic covariates. Advances in clinical and experimental medicine : official organ Wroclaw Medical University 2023 3 . Sridharan Kannan, Banna Rashed Abdulla Al, Husain Ais |
Fibrinogen-A? THR312ALA Polymorphism is Associated to Chronic Thromboembolic Pulmonary Hypertension in Turkey. Anatolian journal of cardiology 2023 3 27 (3): 153-159. Çörtük Mustafa, Y?ld?zeli Bedrettin, Kurar Ercan, Kay?? Seyit Ali, Tanr?verdi Elif, Çetinkaya Erdo? |
Targeted next-generation sequencing of genes involved in Warfarin Pharmacodynamics and pharmacokinetics pathways using the Saudi Warfarin Pharmacogenetic study (SWAP). The pharmacogenomics journal 2023 2 . Ammari Maha Al, Almuzzaini Bader, Al Sulaiman Khalid, AlBalwi Mohammed, Sultana Khizra, Alabdulkareem Ibrahim B, Almakhlafi Nada S, Humoud Anoud Al, Waheeby Mohammed, Balla Munee, Shehri Asma Al, Alharf Adel, Alghamdi Jah |
The prevalence of pharmacogenetic variants of vitamin K epoxide reductase complex subunit 1 gene (rs9923231), cytochrome P450 family 2 subfamily C member 9 gene (rs1799853) and cytochrome P450 family 3 subfamily-A member-5 gene (rs776746) among 13 ethnic groups of Pakistan. Molecular biology reports 2023 2 . Firasat Sadaf, Raza Ali, Khan Abdul Rafay, Abid Aiys |
Warfarin-Rifampin-Gene (WARIF-G) Interaction: A Retrospective, Genetic, Case-Control Study. Clinical pharmacology and therapeutics 2023 2 . Salem Muhammad, El-Bardissy Ahmed, Elshafei Mohamed Nabil, Khalil Ahmed, Mahmoud Hesham, Fahmi Amr Mohamed, Kasem Mohamed, Bader Loulia, Sherbash Mohamed, Elawady Mostafa Ibrahim, Abdalazim Walaa, Howady Faraj, Elewa Haz |
Acute kidney injury interacts with VKORC1 genotype on initiative warfarin dose among heart surgery recipients: a real-world research. Scientific reports 2023 12 13 (1): 21750. Liang Xiong, Feng Yu, Weihong Ge, Hang |
New insights into the role of VKORC1 polymorphisms for optimal warfarin dose selection in Caribbean Hispanic patients through an external validation of a population PK/PD model. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023 12 170 115977. Karine Rodríguez-Fernández, Gledys Reynaldo-Fernández, Stephanie Reyes-González, Camila de Las Barreras, Leyanis Rodríguez-Vera, Cornelis Vlaar, Jean-Christophe M Monbaliu, Torsten Stelzer, Jorge Duconge, Victor Mangas-Sanju |
Association between polymorphisms of the VKORC1 and CYP2C9 genes and warfarin maintenance dose in Peruvian patients. British journal of clinical pharmacology 2023 11 . Teodoro J Oscanoa, María L Guevara-Fujita, Ricardo M Fujita, Maria Y Muñoz-Paredes, Oscar Acosta, Román Romero-Ortu |
Potential Impact of Pharmacogenomic Single Nucleotide Variants in a Rural Caucasian Population. The journal of applied laboratory medicine 2023 1 8 (2): 251-263. Williams Grace R, Tsongalis Gregory J, Lewis Lionel D, Barney Rachael E, Cook Leanne J, Aaron Geno K, Nerenz Robert |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: